立方制药
(003020)
| 流通市值：36.01亿 | | | 总市值：49.73亿 |
| 流通股本：1.38亿 | | | 总股本：1.90亿 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 411,484,493.62 | 439,694,059.59 | 319,783,092.31 | 267,767,285.21 |
| 应收票据及应收账款 | 403,932,219.46 | 369,783,105.03 | 357,146,880.09 | 354,610,757.18 |
| 其中：应收票据 | 760,000 | 760,000 | - | - |
| 应收账款 | 403,172,219.46 | 369,023,105.03 | 357,146,880.09 | 354,610,757.18 |
| 应收款项融资 | 30,625,488.55 | 45,841,955.65 | 45,223,235.33 | 33,284,332.53 |
| 预付款项 | 32,730,075.54 | 10,700,324.42 | 24,593,435.66 | 22,224,545.5 |
| 其他应收款合计 | 10,096,526.61 | 8,077,104.65 | 15,336,614.75 | 14,690,385.1 |
| 存货 | 233,749,768.41 | 220,484,038.25 | 209,906,611.38 | 220,410,196.41 |
| 一年内到期的非流动资产 | 10,747,994.89 | 10,667,993.89 | - | - |
| 其他流动资产 | 20,436,689.28 | 22,246,195.16 | 18,164,854.78 | 20,310,116.1 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 1,193,930,238.63 | 1,185,494,963.22 | 1,158,018,371.95 | 1,091,196,861.68 |
| 非流动资产: | | | | |
| 长期股权投资 | 176,967,615.55 | 174,675,297.68 | 176,061,029.92 | 169,623,694.93 |
| 其他权益工具投资 | 16,439,136.58 | 16,439,136.58 | 19,439,136.58 | 16,439,136.58 |
| 其他非流动金融资产 | 3,000,000 | 3,000,000 | - | - |
| 投资性房地产 | 24,635,243.22 | 24,831,646.35 | 25,028,049.48 | 25,224,452.61 |
| 固定资产 | 678,069,352.1 | 692,904,360.14 | 710,029,543.5 | 587,734,116.34 |
| 在建工程 | 287,167,292.12 | 269,339,840.76 | 223,424,163.87 | 333,441,033.43 |
| 生产性生物资产 | 714,600.45 | 703,409.56 | 2,417,554.17 | 2,417,554.17 |
| 使用权资产 | 9,957,714.8 | 9,799,793.6 | 11,408,725.02 | 12,821,329.27 |
| 无形资产 | 103,644,696.07 | 105,240,152.32 | 106,869,261.64 | 109,004,209.74 |
| 开发支出 | 3,187,200 | 3,067,200 | 2,502,000 | 2,586,000 |
| 商誉 | 74,440,520.92 | 74,440,520.92 | 74,440,520.92 | 74,440,520.92 |
| 长期待摊费用 | 3,278,988.72 | 3,868,659.17 | 4,374,050.46 | 4,945,574.7 |
| 递延所得税资产 | 15,148,206.29 | 14,507,706.15 | 18,485,161.58 | 15,881,231.29 |
| 其他非流动资产 | 5,477,691.88 | 7,662,627.66 | 22,326,396.75 | 38,148,830.27 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 1,402,128,258.7 | 1,400,480,350.89 | 1,396,805,593.89 | 1,392,707,684.25 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 2,596,058,497.33 | 2,585,975,314.11 | 2,554,823,965.84 | 2,483,904,545.93 |
| 流动负债: | | | | |
| 应付票据及应付账款 | 364,146,129.89 | 347,525,164.53 | 328,118,034.48 | 340,436,259.85 |
| 应付账款 | 364,146,129.89 | 347,525,164.53 | 328,118,034.48 | 340,436,259.85 |
| 预收款项 | 5,148 | 766,409.41 | - | - |
| 合同负债 | 16,008,485.54 | 8,768,343.24 | 15,570,255.08 | 11,917,505.14 |
| 应付职工薪酬 | 17,738,925.9 | 34,436,670.49 | 29,085,428.79 | 22,905,514.1 |
| 应交税费 | 28,346,179.73 | 32,102,016.91 | 34,782,389.33 | 39,248,411.09 |
| 其他应付款合计 | 122,210,626.64 | 152,851,088.95 | 121,201,124.93 | 117,283,381.46 |
| 应付股利 | - | 38,252,100 | - | - |
| 一年内到期的非流动负债 | 6,822,015.36 | 4,362,741.69 | 7,184,966.18 | 5,339,444.94 |
| 其他流动负债 | 1,983,046.53 | 1,139,884.62 | 1,861,524.91 | 1,450,495.33 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 557,260,557.59 | 581,952,319.84 | 537,803,723.7 | 538,581,011.91 |
| 非流动负债: | | | | |
| 长期借款 | 59,644,700 | 59,651,852.78 | 59,646,667.5 | 31,025,575 |
| 租赁负债 | 1,378,509.94 | 4,565,409.66 | 2,120,950.66 | 5,121,196.72 |
| 递延收益 | 17,518,163.19 | 18,278,013.3 | 18,271,309.95 | 18,922,137.39 |
| 递延所得税负债 | 8,552,776.98 | 8,929,112.09 | 12,320,544.55 | 11,310,005.81 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 87,094,150.11 | 91,424,387.83 | 92,359,472.66 | 66,378,914.92 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 644,354,707.7 | 673,376,707.67 | 630,163,196.36 | 604,959,926.83 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 191,260,500 | 191,571,763 | 191,571,763 | 191,571,763 |
| 资本公积 | 517,494,830.87 | 518,001,314.36 | 530,912,511.53 | 528,937,051.18 |
| 减:库存股 | 9,080,258.35 | 9,391,521.35 | 20,658,376.8 | 20,658,376.8 |
| 盈余公积 | 97,154,751.67 | 97,154,751.67 | 81,977,401.19 | 81,977,401.19 |
| 未分配利润 | 979,137,008.9 | 940,550,642.68 | 947,902,102.83 | 910,578,560.3 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 1,775,966,833.09 | 1,737,886,950.36 | 1,731,705,401.75 | 1,692,406,398.87 |
| 少数股东权益 | 175,736,956.54 | 174,711,656.08 | 192,955,367.73 | 186,538,220.23 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 1,951,703,789.63 | 1,912,598,606.44 | 1,924,660,769.48 | 1,878,944,619.1 |
| 负债和股东权益合计 | 2,596,058,497.33 | 2,585,975,314.11 | 2,554,823,965.84 | 2,483,904,545.93 |
| 公告日期 | 2025-04-22 | 2025-04-22 | 2024-10-30 | 2024-08-31 |
| 审计意见(境内) | | 标准无保留意见 | | |